Tempol

N/A

Report date: 2025/06/19 16:04:07
NME

Base Information

Drug NameTempol
Drug Alias NameTempol - Matrix Biomed4-oxypiperidolMBM-02OT-674NSC-142784 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitorsInflammation mediator inhibitorsAngiogenesis inhibitors +[5] 
TargetsCoagulation factorSuperoxide dismutaseFree radicals
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Drug-Related Side Effects and Adverse ReactionsAlopecia +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMitos
China Registration ClassN/A

Develop Information

Active CompaniesMatrix Biomed Inc
Inactive CompaniesRecursion Pharmaceuticals IncThe University Of Texas At ArlingtonNational Cancer Institute +[5] 
Active IndicationsDrug-Related Side Effects and Adverse ReactionsOtotoxicityMucositis
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)AlopeciaCardiovascular Diseases +[8] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank